A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes

Patients treated with recombinant human Epo demonstrate an improvement in insulin sensitivity. We aimed to investigate whether CNTO 530, a novel Epo receptor agonist, could affect glucose tolerance and insulin sensitivity. A single administration of CNTO 530 significantly and dose-dependently reduce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scully, Michael S., Ort, Tatiana A., James, Ian E., Bugelski, Peter J., Makropoulos, Dorie A., Deutsch, Heather A., Pieterman, Elsbet J., van den Hoek, Anita M., Havekes, Louis M., duBell, William H., Wertheimer, Joshua D., Picha, Kristen M.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3132469/
https://ncbi.nlm.nih.gov/pubmed/21754921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/910159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados